KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Acquisitions & Divestments (2016 - 2018)

Evolent Health has reported Change in Acquisitions & Divestments over the past 3 years, most recently at $349000.0 for Q4 2018.

  • Quarterly results put Change in Acquisitions & Divestments at $349000.0 for Q4 2018, changed N/A from a year ago — trailing twelve months through Dec 2018 was $349000.0 (down 99.21% YoY), and the annual figure for FY2018 was $349000.0, down 99.21%.
  • Change in Acquisitions & Divestments for Q4 2018 was $349000.0 at Evolent Health, down from $24.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for EVH hit a ceiling of $24.0 million in Q3 2017 and a floor of $349000.0 in Q4 2018.
  • Median Change in Acquisitions & Divestments over the past 3 years was $5.3 million (2016), compared with a mean of $7.7 million.
  • Peak annual rise in Change in Acquisitions & Divestments hit 1100.6% in 2017, while the deepest fall reached 357.62% in 2017.
  • Evolent Health's Change in Acquisitions & Divestments stood at $5.3 million in 2016, then surged by 354.55% to $24.0 million in 2017, then tumbled by 98.55% to $349000.0 in 2018.
  • The last three reported values for Change in Acquisitions & Divestments were $349000.0 (Q4 2018), $24.0 million (Q3 2017), and $9.6 million (Q2 2017) per Business Quant data.